Amy Raskin said on CNBC's "Fast Money Halftime Report" that she would hold Crispr Therapeutics AG (NASDAQ: CRSP). She doesn't own the stock, but she owns Intellia Therapeutics Inc (NASDAQ: NTLA) in the space.
Pete Najarian sees Bed Bath & Beyond Inc. (NASDAQ: BBBY) as a trading vehicle because of volatile trading. A lot of that has to do with the short interest of the company.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.